Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-26-037468

EXEC. CHAIR & PRINCIPAL OFF bought 2,220 shares at $0.32 ($710)

From the SEC's structured data for this filing

Trades in this filing

ARMEN GARO H · EXEC. CHAIR & PRINCIPAL OFF

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-11 Purchase : show line 1 in the form +2,220 $0.32 $710 34,199 D
Open-market purchases · 2,220 sh · avg $0.32 · $710
Loading xslF345X06/ownership.xml…